학술논문

Corrigendum: Metagenome Analysis of Intestinal Bacteria in Healthy People, Patients With Inflammatory Bowel Disease and Colorectal Cancer.
Document Type
Author
Ma Y; Laboratory of Molecular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou, China.; South Sichuan Institute of Translational Medicine, Luzhou, China.; Zhang Y; Laboratory of Molecular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou, China.; South Sichuan Institute of Translational Medicine, Luzhou, China.; Jiang H; Department of Gastrointestinal Surgery, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College), Wuhu, China.; Xiang S; Laboratory of Molecular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou, China.; South Sichuan Institute of Translational Medicine, Luzhou, China.; Zhao Y; Laboratory of Molecular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou, China.; South Sichuan Institute of Translational Medicine, Luzhou, China.; Xiao M; Laboratory of Molecular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou, China.; South Sichuan Institute of Translational Medicine, Luzhou, China.; Du F; Laboratory of Molecular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou, China.; South Sichuan Institute of Translational Medicine, Luzhou, China.; Ji H; Laboratory of Molecular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou, China.; South Sichuan Institute of Translational Medicine, Luzhou, China.; Kaboli PJ; Laboratory of Molecular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou, China.; South Sichuan Institute of Translational Medicine, Luzhou, China.; Wu X; Laboratory of Molecular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou, China.; South Sichuan Institute of Translational Medicine, Luzhou, China.; Li M; Laboratory of Molecular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou, China.; South Sichuan Institute of Translational Medicine, Luzhou, China.; Wen Q; Department of Oncology, Affiliated Hospital of Southwest Medical University, Luzhou, China.; Shen J; Laboratory of Molecular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou, China.; South Sichuan Institute of Translational Medicine, Luzhou, China.; Yang Z; Department of Oncology and Hematology, Hospital (T.C.M) Affiliated to Southwest Medical University, Luzhou, China.; Li J; Department of Oncology and Hematology, Hospital (T.C.M) Affiliated to Southwest Medical University, Luzhou, China.; Xiao Z; Laboratory of Molecular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou, China.; Department of Pharmacy, The Affiliated Hospital of Southwest Medical University, Luzhou, China.
Source
Publisher: Frontiers Media SA Country of Publication: Switzerland NLM ID: 101585359 Publication Model: eCollection Cited Medium: Internet ISSN: 2235-2988 (Electronic) Linking ISSN: 22352988 NLM ISO Abbreviation: Front Cell Infect Microbiol Subsets: PubMed not MEDLINE; MEDLINE
Subject
Language
English
Abstract
[This corrects the article DOI: 10.3389/fcimb.2021.599734.].
(Copyright © 2021 Ma, Zhang, Jiang, Xiang, Zhao, Xiao, Du, Ji, Kaboli, Wu, Li, Wen, Shen, Yang, Li and Xiao.)